Puma Biotechnology (PBYI) Payables (2011 - 2026)
Puma Biotechnology (PBYI) reported Payables of $3.11 million for Q2 2026, down 42.8% from $5.42 million a year earlier and down 62.0% from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025, Puma Biotechnology posted Payables of $5.06 million, down 8.2% from FY2024.
- Payables has a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
- By year, Payables came in at $5.51 million in FY2024 (-20.0%), $6.89 million in FY2023 (+7.0%), $6.44 million in FY2022 (-42.4%) and $11.17 million in FY2021 (-7.5%).
- The Q2 2026 figure ranks as the lowest quarterly Payables since Q4 2012.
- Year over year, Payables gained in two of the last eight quarters, with an average decline of 11.8%.
- The high point for year-over-year Payables in five years was Q2 2024 (growth of 73.2%); the low point was Q3 2023 (a decline of 66.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.17 million (Q1 2026), $5.06 million (Q4 2025) and $6.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 3.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.11 Mn |
| Mar 31, 2026 | 8.17 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 6.39 Mn |
| Jun 30, 2025 | 5.42 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Sep 30, 2024 | 7.51 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 8.96 Mn |
| Dec 31, 2023 | 6.89 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 7.80 Mn |
| Mar 31, 2023 | 8.59 Mn |
| Dec 31, 2022 | 6.44 Mn |
| Sep 30, 2022 | 14.93 Mn |
| Jun 30, 2022 | 9.84 Mn |
| Mar 31, 2022 | 7.41 Mn |
| Dec 31, 2021 | 11.17 Mn |
| Sep 30, 2021 | 20.05 Mn |
API Access
Puma Biotechnology Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();